- Home
- TRVG vs ENGN Comparison
TRVG vs ENGN Comparison
Compare TRVG & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVG
- ENGN
- Stock Information
- Founded
- TRVG 2005
- ENGN 1999
- Country
- TRVG Germany
- ENGN Canada
- Employees
- TRVG N/A
- ENGN N/A
- Industry
- TRVG EDP Services
- ENGN
- Sector
- TRVG Technology
- ENGN
- Exchange
- TRVG Nasdaq
- ENGN Nasdaq
- Market Cap
- TRVG 306.5M
- ENGN 297.7M
- IPO Year
- TRVG N/A
- ENGN N/A
- Fundamental
- Price
- TRVG $4.73
- ENGN $4.30
- Analyst Decision
- TRVG Hold
- ENGN Buy
- Analyst Count
- TRVG 5
- ENGN 9
- Target Price
- TRVG $2.94
- ENGN $25.22
- AVG Volume (30 Days)
- TRVG 121.2K
- ENGN 28.9K
- Earning Date
- TRVG 04-29-2025
- ENGN 03-10-2025
- Dividend Yield
- TRVG N/A
- ENGN N/A
- EPS Growth
- TRVG N/A
- ENGN N/A
- EPS
- TRVG N/A
- ENGN N/A
- Revenue
- TRVG $477,118,749.00
- ENGN N/A
- Revenue This Year
- TRVG $9.85
- ENGN N/A
- Revenue Next Year
- TRVG $6.77
- ENGN N/A
- P/E Ratio
- TRVG N/A
- ENGN N/A
- Revenue Growth
- TRVG N/A
- ENGN N/A
- 52 Week Low
- TRVG $1.60
- ENGN $4.20
- 52 Week High
- TRVG $5.45
- ENGN $17.54
- Technical
- Relative Strength Index (RSI)
- TRVG 55.76
- ENGN 31.38
- Support Level
- TRVG $4.63
- ENGN $4.20
- Resistance Level
- TRVG $5.45
- ENGN $5.00
- Average True Range (ATR)
- TRVG 0.39
- ENGN 0.51
- MACD
- TRVG 0.01
- ENGN -0.04
- Stochastic Oscillator
- TRVG 53.46
- ENGN 7.14
Stock Price Comparison Chart: TRVG vs ENGN
About TRVG trivago N.V.
trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.